Eris Lifesciences share news, announcements and annual reports
NSE: ERISBSE: 540596Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,163.60.
30 Oct: open ₹1,163.00, high ₹1,174.70, low ₹1,148.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹16,044 Cr353rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 22.67
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.87
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.62%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 19.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 13.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.58
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 31,21340.7% delivered
Eris Lifesciences has 795 announcements on record, routine notices left out; 5 in the 30 days to 1 Nov 2026, the latest on 29 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Eris Lifesciences quarterly results
The board met on 26 Oct 2026 to consider financial results
Notice filed 19 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Eris Lifesciences annual reports, presentations and earnings calls
The company's own documents, latest first.Eris Lifesciences financials, year by year
Annual reports10
- Annual report, year to Mar 20262 Sep 2026
- Annual report, year to Mar 20252 Jul 2025
- Annual report, year to Mar 20242 Sep 2024
- Annual report, year to Mar 20232 Sep 2023, a zip file
- Annual report, year to Mar 20225 Aug 2022, a zip file
5 earlier reports
- Annual report, year to Mar 20214 Aug 2021, a zip file
- Annual report, year to Mar 20207 Sep 2020, a zip file
- Annual report, year to Mar 20193 Sep 2019, a zip file
- Annual report, year to Mar 201829 Sep 2018, a zip file
- Annual report, year to Mar 20174 Oct 2017, a zip file
Investor presentations51
- Investor Presentation26 Oct 2026
- Investor Presentation29 Jul 2026
- Corporate presentation23 Jun 2026
- Investor Presentation20 May 2026
- Corporate Presentation20 Feb 2026
46 earlier presentations
- Investor Presentation13 Feb 2026
- Corporate Presentation3 Dec 2025
- Investor Presentation12 Nov 2025
- Investor Presentation5 Aug 2025
- Corporate Presentation26 Jun 2025
- Investor Presentation19 May 2025
- Investor Presentation4 Feb 2025
- Investor Presentation25 Oct 2024
- Investor Presentation2 Aug 2024
- Corporate Presentation10 Jun 2024
- Corporate Presentation1 Jun 2024
- Investor Presentation21 May 2024
- Investor Presentation14 Mar 2024
- Investor Presentation13 Feb 2024
- Corporate presentation23 Nov 2023
- Presentation8 Nov 2023
- Corporate Presentation17 Aug 2023
- Investor Presentation7 Aug 2023
- Corporate Presentation14 Jun 2023
- Investor Presentation17 May 2023
- Investor Presentation17 Jan 2023
- Corporate Presentation.3 Nov 2022
- Investor Presentation20 Oct 2022
- Corporate Presentation10 Aug 2022
- Investor Presentation5 Aug 2022
- Corporate Presentation18 May 2022
- Investor Presentation3 May 2022
- Investor Presentation2 Feb 2022
- Investor Presentation28 Jan 2022
- Corporate Presentation30 Oct 2021
- Investor Presentation29 Oct 2021
- Investor Presentation3 Aug 2021
- Investor Presentation29 Jul 2021
- Investor Presentation13 May 2021
- Investor Presentation28 Jan 2021
- Investor Presentation3 Nov 2020
- Investor Presentation4 Aug 2020
- Investor Presentation26 Jun 2020
- Investor Presentation2 Jun 2020
- Investor Presentation14 Feb 2020
- Investor Presentation7 Nov 2019
- Investor Presentation27 Jul 2019
- Investor Presentation21 May 2019
- Investor Presentation29 Jan 2019
- Investor Presentation3 Nov 2018
- Investor Presentation10 Aug 2018, a zip file
Earnings calls50
- Transcript29 Oct 2026
- Link of Recording26 Oct 2026
- Transcript4 Aug 2026
- Link of Recording29 Jul 2026
- Transcript26 May 2026
45 earlier call documents
- Link of Recording20 May 2026
- Transcript20 Feb 2026
- Link of Recording13 Feb 2026
- Transcript14 Nov 2025
- Link of Recording12 Nov 2025
- Transcript11 Aug 2025
- Link of Recording5 Aug 2025
- Transcript26 May 2025
- Link of Recording19 May 2025
- Transcript11 Feb 2025
- Link of Recording4 Feb 2025
- Transcript4 Nov 2024
- Link of Recording25 Oct 2024
- Transcript7 Aug 2024
- Link of recordings2 Aug 2024
- Transcript28 May 2024
- Link of Recording21 May 2024
- Transcript21 Mar 2024
- Link of Recording14 Mar 2024
- Transcript20 Feb 2024
- Link of Recording13 Feb 2024
- Transcript11 Nov 2023
- Link of Recording8 Nov 2023
- Transcript11 Aug 2023
- Link of Recording7 Aug 2023
- Transcript22 May 2023
- Link of Recording17 May 2023
- Transcript23 Mar 2023
- Link of Recording16 Mar 2023
- Transcript23 Jan 2023
- AUDIO RECORDING OF THE EARNINGS CONFERENCE CALL ON THE UNAUDITED CONSOLIDATED AND STANDALONE FINANCIAL RESULTS OF THE COMPANY FOR THE QUARTER AND NINE MONTHS ENDED 31ST DECEMBER 202217 Jan 2023
- Transcript of Analysts/Institutional Investor Meet/Con. Call31 Oct 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call20 Oct 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call11 Aug 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call5 Aug 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call10 May 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call5 May 2022
- Transcript3 Feb 2022
- Transcript9 Dec 2021
- Analysts/Institutional Investor Meet/Con. Call Updates [Transcript of call]17 Feb 2020
- Analysts/Institutional Investor Meet/Con. Call Updates [Transcript of call]12 Nov 2019
- Analysts/Institutional Investor Meet/Con. Call Updates Transcript of call5 Aug 2019
- Analysts/Institutional Investor Meet/Con. Call Updates Transcript of call27 May 2019
- Analysts/Institutional Investor Meet/Con. Call Updates/ TRANSCRIPT OF ANALYST AND INVESTOR CALL31 May 2018, a zip file
- Transcript of the Analyst and Investor Conference call23 Nov 2017, a zip file
Eris Lifesciences merger and demerger filings
Filings about a merger, demerger or scheme of arrangement, latest first.
Filings1
- Scheme of Arrangement2 Aug 2024
Eris Lifesciences share news and announcements
Newest first. Page 1 of 16.
Oct 2026
29 Oct · Analysts
26 Oct · Results
19 Oct · Analysts
19 Oct · Board meeting
Sep 2026
25 Sep · Meeting
9 Sep · Business
7 Sep · Analysts
Aug 2026
31 Aug · Board meeting
24 Aug · Analysts
12 Aug · Analysts
10 Aug · Analysts
6 Aug · Business
Jul 2026
30 Jul · Analysts
30 Jul · Disclosure
29 Jul · Results
23 Jul · Analysts
23 Jul · Board meeting
Jun 2026
26 Jun · Disclosure
May 2026
28 May · Legal
25 May · Analysts
20 May · Results
15 May · Analysts
12 May · Updates
11 May · Disclosure
8 May · Rating
Apr 2026
23 Apr · Meeting
20 Apr · Updates
Mar 2026
20 Mar · Board meeting
13 Mar · Analysts
12 Mar · Disclosure
5 Mar · Analysts
Feb 2026
28 Feb · Legal
23 Feb · Analysts
19 Feb · Analysts
13 Feb · Board meeting
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 26 Oct 2026Resultsup 0.89%0.0 pts vs Nifty 500market median −0.7% · five sessions +5.6% (+3.4 pts vs Nifty 500) · volume 3.4× usual · delivery −26.4 pts against usual · The announcement
- 5 Oct 2026Board or managers changeddown 0.10%−0.6 pts vs Nifty 500market median 0.0% · five sessions −1.6% (−1.6 pts vs Nifty 500) · volume 0.5× usual · delivery +18.8 pts against usual · The announcement
- 15 Sep 2026Board or managers changeddown 3.35%−1.6 pts vs Nifty 500market median 0.0% · five sessions −4.4% (−4.4 pts vs Nifty 500) · volume 0.7× usual · delivery −3.9 pts against usual · The announcement
- 29 Jul 2026Resultsup 2.57%+1.5 pts vs Nifty 500market median −0.7% · five sessions −1.3% (−3.8 pts vs Nifty 500) · volume 5.1× usual · delivery −34.2 pts against usual · The announcement
- 20 May 2026Resultsup 9.13%+8.9 pts vs Nifty 500market median −0.7% · five sessions +1.9% (+0.2 pts vs Nifty 500) · volume 13.0× usual · delivery −31.9 pts against usual · The announcement
- 11 May 2026Credit ratingdown 0.70%+0.7 pts vs Nifty 500market median 0.0% · five sessions −1.1% (+1.4 pts vs Nifty 500) · volume 0.3× usual · delivery −20.6 pts against usual · The announcement
- 13 Feb 2026Resultsdown 6.36%−4.9 pts vs Nifty 500market median −0.7% · five sessions −12.0% (−10.6 pts vs Nifty 500) · volume 4.2× usual · delivery −18.9 pts against usual · The announcement
- 19 Dec 2025Board or managers changedup 1.26%+0.5 pts vs Nifty 500market median 0.0% · five sessions −1.7% (−2.9 pts vs Nifty 500) · volume 0.1× usual · delivery +8.8 pts against usual · The announcement
- 13 Nov 2025Resultsdown 3.62%−3.5 pts vs Nifty 500market median −0.7% · five sessions +2.3% (+2.0 pts vs Nifty 500) · volume 1.3× usual · delivery −15.0 pts against usual · The announcement
- 14 Aug 2025Board or managers changedup 0.58%+0.7 pts vs Nifty 500market median 0.0% · five sessions +4.6% (+2.7 pts vs Nifty 500) · volume 0.3× usual · delivery +9.2 pts against usual · The announcement
20 earlier announcements
- 5 Aug 2025Resultsup 0.28%+0.5 pts vs Nifty 500market median −0.7% · five sessions −4.4% (−3.4 pts vs Nifty 500) · volume 3.2× usual · delivery −34.2 pts against usual · The announcement
- 20 May 2025Resultsup 1.84%+3.1 pts vs Nifty 500market median −0.7% · five sessions +6.8% (+6.6 pts vs Nifty 500) · volume 1.5× usual · delivery −18.6 pts against usual · The announcement
- 12 May 2025Credit ratingdown 3.51%−7.4 pts vs Nifty 500market median 0.0% · five sessions +0.6% (−4.9 pts vs Nifty 500) · volume 1.7× usual · delivery +11.5 pts against usual · The announcement
- 6 May 2025Credit ratingdown 3.19%−2.1 pts vs Nifty 500market median 0.0% · five sessions −6.8% (−8.2 pts vs Nifty 500) · volume 0.6× usual · delivery +7.3 pts against usual · The announcement
- 7 Feb 2025Dividendup 1.73%+1.9 pts vs Nifty 500market median 0.0% · five sessions −13.0% (−9.4 pts vs Nifty 500) · volume 2.3× usual · delivery −32.9 pts against usual · The announcement
- 25 Oct 2024Resultsup 0.64%+1.9 pts vs Nifty 500market median −0.7% · five sessions +3.1% (+3.5 pts vs Nifty 500) · volume 1.1× usual · delivery −17.2 pts against usual · The announcement
- 30 May 2024Credit ratingup 0.10%+1.1 pts vs Nifty 500market median 0.0% · five sessions +0.6% (+1.5 pts vs Nifty 500) · volume 0.3× usual · delivery +5.9 pts against usual · The announcement
- 7 Feb 2024Credit ratingup 2.65%+2.3 pts vs Nifty 500market median 0.0% · five sessions +4.4% (+5.7 pts vs Nifty 500) · volume 0.6× usual · delivery +18.7 pts against usual · The announcement
- 7 Aug 2023Resultsup 3.45%+3.1 pts vs Nifty 500market median −0.7% · five sessions +2.6% (+2.8 pts vs Nifty 500) · volume 1.1× usual · delivery −48.1 pts against usual · The announcement
- 18 May 2023Credit ratingdown 1.18%−0.8 pts vs Nifty 500market median 0.0% · five sessions −2.6% (−3.2 pts vs Nifty 500) · volume 2.2× usual · delivery +30.7 pts against usual · The announcement
- 8 May 2023Credit ratingup 0.69%−0.3 pts vs Nifty 500market median 0.0% · five sessions +1.0% (−0.3 pts vs Nifty 500) · volume 0.6× usual · delivery +1.1 pts against usual · The announcement
- 20 Oct 2022Resultsdown 2.92%−3.2 pts vs Nifty 500market median −0.7% · five sessions −0.3% (−1.5 pts vs Nifty 500) · volume 2.0× usual · delivery −1.2 pts against usual · The announcement
- 5 Aug 2022Resultsdown 0.81%−0.9 pts vs Nifty 500market median −0.7% · five sessions −0.8% (−2.4 pts vs Nifty 500) · volume 3.9× usual · delivery −37.3 pts against usual · The announcement
- 5 Aug 2022Dividenddown 0.81%−0.9 pts vs Nifty 500market median 0.0% · five sessions −0.8% (−2.4 pts vs Nifty 500) · volume 3.9× usual · delivery −37.3 pts against usual · The announcement
- 20 Jul 2022Board or managers changeddown 1.00%−1.8 pts vs Nifty 500market median 0.0% · five sessions +0.3% (−0.4 pts vs Nifty 500) · volume 0.9× usual · delivery −4.4 pts against usual · The announcement
- 28 Jan 2022Resultsdown 2.04%−2.3 pts vs Nifty 500market median −0.7% · five sessions −1.1% (−4.2 pts vs Nifty 500) · volume 3.2× usual · delivery −19.4 pts against usual · The announcement
- 29 Jul 2021Dividendup 3.91%+3.4 pts vs Nifty 500market median 0.0% · five sessions +1.9% (−0.9 pts vs Nifty 500) · volume 2.4× usual · delivery −20.7 pts against usual · The announcement
- 17 May 2021Resultsup 5.78%+4.2 pts vs Nifty 500market median −0.7% · five sessions +5.7% (+2.1 pts vs Nifty 500) · volume 3.6× usual · delivery −21.4 pts against usual · The announcement
- 28 Jan 2021Resultsup 2.03%+2.9 pts vs Nifty 500market median −0.7% · five sessions −2.4% (−7.8 pts vs Nifty 500) · volume 2.1× usual · delivery −22.5 pts against usual · The announcement
- 14 Sep 2020Board or managers changedup 5.73%+5.2 pts vs Nifty 500market median 0.0% · five sessions +10.1% (+8.9 pts vs Nifty 500) · volume 2.8× usual · delivery −5.6 pts against usual · The announcement
Eris Lifesciences results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Revenue from operations | Quarter to Jun 2024 | Consolidated | 719.72 | 715.59 | −0.6% | 5 Aug 2024 | 28 Oct 2024 |
| Other income | Quarter to Jun 2024 | Consolidated | 1.64 | 5.77 | +251.8% | 5 Aug 2024 | 28 Oct 2024 |